Scientific Reports · 2018 · 17 citations · 48 references
Life SciencesImmunologyInfectious DiseasesAntibody EngineeringImmunology Of Infectious DiseasesImmunotherapyBispecific AntibodiesBispecific Antibody TherapyCancer ImmunotherapyCell-mediated ImmunityCellular Immunity In InfectionT Cell ActivationBispecific Antibody ConjugatesBispecific Antibody FragmentsBispecific Antibody SelectionCd3-directed Bispecific AntibodiesCytomegalovirus TherapyImmune Cell Cytokine ProductionInflammatory Cytokine ProductionT Cell Cytokine Production
Bispecific T cell engager (BiTE) antibody constructs are successfully used as cancer therapeutics. We hypothesized that this treatment strategy could also be applicable for therapy of human cytomegalovirus (HCMV) infection, since HCMV-encoded proteins are abundantly expressed on the surface of infected cells. Here we show that a BiTE antibody construct directed against HCMV glycoprotein B (gB) and CD3 efficiently triggers T cells to secrete IFN-γ and TNF upon co-culture with fibroblasts infected with HCMV strain AD169, Towne or Toledo. Titration of gB expression levels in non-infected cells confirmed that already low levels of gB are sufficient for efficient triggering of T cells in presence of the BiTE antibody construct. Comparison of redirecting T cells with the bispecific antibody versus a chimeric antigen receptor (CAR) based on the same scFv showed a similar sensitivity for gB expression. Although lysis of infected target cells was absent, the BiTE antibody construct inhibited HCMV replication by triggering cytokine production. Notably, even strongly diluted supernatants of the activated T cells efficiently blocked the replication of HCMV in infected primary fibroblasts. In summary, our data prove the functionality of the first BiTE antibody construct targeting an HCMV-encoded glycoprotein for inhibiting HCMV replication in infected cells.
48
A simple method of estimating 50 per cent end points
Hr Muench · Medical Entomology and Zoology · 1938 · 8.4K citations
Genetic Analysis of Human Norovirus Strains in Japan in 2016–2017
Koo Nagasawa, Yuki Matsushima, Takumi Motoya et al. · Frontiers in Microbiology · 2018 · 1.3K citations · Full text
Yvonne A. Lipsewers, Ellen C. Hopmans, Filip J. R. Meysman et al. · Frontiers in Microbiology · 2016 · 948 citations · Full text
Life Sciences, Biology, Microbiology +17